A citation-based method for searching scientific literature

Faramarz Ismail-Beigi, Timothy Craven, Mary Ann Banerji, Jan Basile, Jorge Calles, Robert M Cohen, Robert Cuddihy, William C Cushman, Saul Genuth, Richard H Grimm, Bruce P Hamilton, Byron Hoogwerf, Diane Karl, Lois Katz, Armand Krikorian, Patrick O'Connor, Rodica Pop-Busui, Ulrich Schubart, Debra Simmons, Harris Taylor, Abraham Thomas, Daniel Weiss, Irene Hramiak. Lancet 2010
Times Cited: 807







List of co-cited articles
894 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
37

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
28

Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
Rodica Pop-Busui, Andrew J M Boulton, Eva L Feldman, Vera Bril, Roy Freeman, Rayaz A Malik, Jay M Sosenko, Dan Ziegler. Diabetes Care 2017
601
23


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
21

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
17

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
16

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
16

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
14

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
14


Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.
Rodica Pop-Busui, Jiang Lu, Maria Mori Brooks, Stewart Albert, Andrew D Althouse, Jorge Escobedo, Jenifer Green, Pasquale Palumbo, Bruce A Perkins, Fred Whitehouse,[...]. Diabetes Care 2013
76
18


Vascular risk factors and diabetic neuropathy.
Solomon Tesfaye, Nish Chaturvedi, Simon E M Eaton, John D Ward, Christos Manes, Constantin Ionescu-Tirgoviste, Daniel R Witte, John H Fuller. N Engl J Med 2005
745
13

Enhanced glucose control for preventing and treating diabetic neuropathy.
Brian C Callaghan, Ann A Little, Eva L Feldman, Richard A C Hughes. Cochrane Database Syst Rev 2012
247
13

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
12

Effect of a multifactorial intervention on mortality in type 2 diabetes.
Peter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2008
12

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
11

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
Peter Gaede, Pernille Vedel, Nicolai Larsen, Gunnar V H Jensen, Hans-Henrik Parving, Oluf Pedersen. N Engl J Med 2003
10

Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
James W Albers, William H Herman, Rodica Pop-Busui, Eva L Feldman, Catherine L Martin, Patricia A Cleary, Barbara H Waberski, John M Lachin. Diabetes Care 2010
207
10

Diabetic kidney disease: a report from an ADA Consensus Conference.
Katherine R Tuttle, George L Bakris, Rudolf W Bilous, Jane L Chiang, Ian H de Boer, Jordi Goldstein-Fuchs, Irl B Hirsch, Kamyar Kalantar-Zadeh, Andrew S Narva, Sankar D Navaneethan,[...]. Diabetes Care 2014
426
10

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.
Solomon Tesfaye, Andrew J M Boulton, Peter J Dyck, Roy Freeman, Michael Horowitz, Peter Kempler, Giuseppe Lauria, Rayaz A Malik, Vincenza Spallone, Aaron Vinik,[...]. Diabetes Care 2010
10

Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Sophia Zoungas, John Chalmers, Bruce Neal, Laurent Billot, Qiang Li, Yoichiro Hirakawa, Hisatomi Arima, Helen Monaghan, Rohina Joshi, Stephen Colagiuri,[...]. N Engl J Med 2014
342
9

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.
Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman. N Engl J Med 2016
9

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
9

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
455
8

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B M Brenner, M E Cooper, D de Zeeuw, W F Keane, W E Mitch, H H Parving, G Remuzzi, S M Snapinn, Z Zhang, S Shahinfar. N Engl J Med 2001
8


Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
Peter Gæde, Jens Oellgaard, Bendix Carstensen, Peter Rossing, Henrik Lund-Andersen, Hans-Henrik Parving, Oluf Pedersen. Diabetologia 2016
215
8

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
Vlado Perkovic, Hiddo Lambers Heerspink, John Chalmers, Mark Woodward, Min Jun, Qiang Li, Stephen MacMahon, Mark E Cooper, Pavel Hamet, Michel Marre,[...]. Kidney Int 2013
180
8

Kidney disease and increased mortality risk in type 2 diabetes.
Maryam Afkarian, Michael C Sachs, Bryan Kestenbaum, Irl B Hirsch, Katherine R Tuttle, Jonathan Himmelfarb, Ian H de Boer. J Am Soc Nephrol 2013
482
8


Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation.
Shazli Azmi, Maria Jeziorska, Maryam Ferdousi, Ioannis N Petropoulos, Georgios Ponirakis, Andrew Marshall, Uazman Alam, Omar Asghar, Andrew Atkinson, Wendy Jones,[...]. Diabetologia 2019
45
17


Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
Vasilios Papademetriou, Laura Lovato, Michael Doumas, Eric Nylen, Amy Mottl, Robert M Cohen, William B Applegate, Zubin Puntakee, Jean Francois Yale, William C Cushman. Kidney Int 2015
100
7

Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
7

Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
7

Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain.
Solomon Tesfaye, Stefan Wilhelm, Alberto Lledo, Alexander Schacht, Thomas Tölle, Didier Bouhassira, Giorgio Cruccu, Vladimir Skljarevski, Rainer Freynhagen. Pain 2013
134
7

Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark.
Signe T Andersen, Daniel R Witte, Else-Marie Dalsgaard, Henning Andersen, Peter Nawroth, Thomas Fleming, Troels M Jensen, Nanna B Finnerup, Troels S Jensen, Torsten Lauritzen,[...]. Diabetes Care 2018
68
10


Gabapentin for chronic neuropathic pain in adults.
Philip J Wiffen, Sheena Derry, Rae F Bell, Andrew Sc Rice, Thomas Rudolf Tölle, Tudor Phillips, R Andrew Moore. Cochrane Database Syst Rev 2017
144
7

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis, L G Hunsicker, W R Clarke, T Berl, M A Pohl, J B Lewis, E Ritz, R C Atkins, R Rohde, I Raz. N Engl J Med 2001
7

Surrogate markers of small fiber damage in human diabetic neuropathy.
Cristian Quattrini, Mitra Tavakoli, Maria Jeziorska, Panagiotis Kallinikos, Solomon Tesfaye, Joanne Finnigan, Andrew Marshall, Andrew J M Boulton, Nathan Efron, Rayaz A Malik. Diabetes 2007
348
7

Lifestyle intervention for pre-diabetic neuropathy.
A Gordon Smith, James Russell, Eva L Feldman, Jonathan Goldstein, Amanda Peltier, Sheldon Smith, Jouhaina Hamwi, Donald Pollari, Billie Bixby, James Howard,[...]. Diabetes Care 2006
339
7

The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
Neda Laiteerapong, Sandra A Ham, Yue Gao, Howard H Moffet, Jennifer Y Liu, Elbert S Huang, Andrew J Karter. Diabetes Care 2019
111
7


IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
7

Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes.
Fukashi Ishibashi, Miki Taniguchi, Aiko Kosaka, Harumi Uetake, Mitra Tavakoli. Diabetes Care 2019
26
26

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial.
Katherine R Tuttle, Mark C Lakshmanan, Brian Rayner, Robert S Busch, Alan G Zimmermann, D Bradley Woodward, Fady T Botros. Lancet Diabetes Endocrinol 2018
178
6

Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.
Rodney A Hayward, Peter D Reaven, Wyndy L Wiitala, Gideon D Bahn, Domenic J Reda, Ling Ge, Madeline McCarren, William C Duckworth, Nicholas V Emanuele. N Engl J Med 2015
363
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.